Enforcing security within a data platform
US-2026017391-A1 · Jan 15, 2026 · US
This page is not indexed by search engines while we improve data quality.
Koenig Patrick patents
Koenig Patrick is listed as an inventor on 33 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Koenig Patrick |
| Total patents | 33 |
| First publication | Sep 8, 2016 |
| Latest publication | Jan 15, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Enforcing security within a data platform
US-12499254-B2 · Dec 16, 2025 · US
Dual specific antibodies
US-2025346661-A1 · Nov 13, 2025 · US
Data analytic systems
US-2025124008-A1 · Apr 17, 2025 · US
Dual specific antibodies
US-2025109195-A1 · Apr 3, 2025 · US
Antigen binding proteins
US-2025084172-A1 · Mar 13, 2025 · US
Optimized variants of anti-VEGF antibodies
US-12121586-B2 · Oct 22, 2024 · US
Data analytic systems
US-12105682-B2 · Oct 1, 2024 · US
Dual specific antibodies
US-2024279327-A1 · Aug 22, 2024 · US
Anti-ULBP6 antibodies
US-12060426-B2 · Aug 13, 2024 · US
Recent patents
Latest publications not already listed above.
Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)
US-12006360-B2 · Jun 11, 2024 · US
Data analytic systems
US-2024086376-A1 · Mar 14, 2024 · US
Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer
US-11891437-B2 · Feb 6, 2024 · US
Antigen binding proteins
US-2023348604-A1 · Nov 2, 2023 · US
Data analytic systems
US-11789912-B2 · Oct 17, 2023 · US
Enforcing security within a data platform
US-2022414239-A1 · Dec 29, 2022 · US
Data analytic systems
US-2022365911-A1 · Nov 17, 2022 · US
Data analytic systems
US-11354281-B2 · Jun 7, 2022 · US
Optimized antibody compositions for treatment of ocular disorders
US-2021363231-A1 · Nov 25, 2021 · US
Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymer
US-11111291-B2 · Sep 7, 2021 · US
Optimized variants of anti-vegf antibodies
US-2021115124-A1 · Apr 22, 2021 · US
Polynucleotides encoding optimized variants of anti-VEGF antibodies
US-10906968-B2 · Feb 2, 2021 · US
Optimized variants of anti-vegf antibodies and methods of use thereof in treatment
US-10899828-B2 · Jan 26, 2021 · US
Dual specific antibodies
US-2020255512-A1 · Aug 13, 2020 · US
Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
US-2020222547-A1 · Jul 16, 2020 · US
Dual specific antibodies
US-10683348-B2 · Jun 16, 2020 · US
Optimized antibody compositions for treatment of ocular disorders
US-2020002411-A1 · Jan 2, 2020 · US
Data analytic systems
US-2019114335-A1 · Apr 18, 2019 · US
Optimized variants of anti-vegf antibodies
US-2019100581-A1 · Apr 4, 2019 · US
Optimized variants of anti-vegf antibodies
US-2019031750-A1 · Jan 31, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Genentech Inc | 20 |
| Palantir Technologies Inc | 10 |
| 23Andme Inc | 3 |
| Glaxosmithkline Intellectual Property No 3 Ltd | 3 |
| Ascendis Pharma As | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 23 |
| C07K2317/92 | 22 |
| C07K2317/567 | 20 |
| C07K2317/31 | 19 |
| C07K2317/56 | 19 |